Our results showed that the expression of HSPA5 was increased in NPC tissues compared to benign nasopharyngeal masses; HSPA5 was expressed more obviously in the recurrent radioresistant NPC tissues compared to the radiosensitivity NPC. The gene discussed is HSPA5; the disease is nasopharyngeal carcinoma.